نتائج البحث

Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Therapy in the Initial Treatment of Helicobacter Pylori.

• Authors : Yongquan Shi, professor

• Source: Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Therapy in the Initial Treatment

تفاصيل العنوان

Esomeprazole/Vonoprazan Combined With High-dose Amoxicillin Dual Therapy for Primary Eradication of Helicobacter Pylori Infection

• Authors : The Second People's Hospital of Huaihua; Yueyang Hospital of Traditional Chinese Medicine; Fen Wang, Professor

• Source: Esomeprazole / Vonoprazan Combined With High-dose Amoxicillin Dual Therapy for Primary Eradication of Helicobacter Pylori Infection: a Multi-center, Prospective,

تفاصيل العنوان

A comparative study of 14-day dual therapy (esomeprazole and amoxicillin four times daily) and triple plus bismuth therapy for first-line Helicobacter pylori infection eradication: A randomized trial.

• Authors : Song Z; Department of Gastroenterology, Peking University Third Hospital, Beijing, China.; Zhou L

Subjects: Amoxicillin*/Amoxicillin*/Amoxicillin*/therapeutic use ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/therapeutic use ; Bismuth*/Bismuth*/Bismuth*/therapeutic use

• Source: Helicobacter [Helicobacter] 2020 Dec; Vol. 25 (6), pp. e12762. Date of Electronic Publication: 2020 Oct 11.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9605411 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy

• Authors : Yongquan Shi, Professor

• Source: Rescue Therapy for Helicobacter Pylori Eradication: A Randomized and Non-inferiority Trail of High-dose Esomeprazole and Amoxicillin Dual Therapy Versus

تفاصيل العنوان

A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection

• Source: A Randomized Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral TAK-438 20 mg Compared to

تفاصيل العنوان

Pharmacokinetics, Safety, and Tolerability of Vonoprazan‐ or Esomeprazole‐Based Bismuth‐Containing Quadruple Therapy: A Phase 1, Double‐Blind, Parallel‐Group Study in Adults with Helicobacter pylori Infection in China.

• Authors : Miao, Jia^1,2 (AUTHOR) ; Hu, Chao² (AUTHOR); Tang, Jie² (AUTHOR)

• Source: Clinical Pharmacology in Drug Development. Oct2023, Vol. 12 Issue 10, p1036-1044. 9p.

تفاصيل العنوان

Bismuth salts with versus without acid suppression for Helicobacter pylori infection: A transmission electron microscope study.

• Authors : Chiang TH; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Integrated Diagnostics and Therapeutics, National Taiwan University Hospital, Taipei, Taiwan.

Subjects: Bismuth*/Bismuth*/Bismuth*/therapeutic use ; Helicobacter Infections*/Helicobacter Infections*/Helicobacter Infections*/drug therapy; Proton Pump Inhibitors/Proton Pump Inhibitors/Proton Pump Inhibitors/*therapeutic use

• Source: Helicobacter [Helicobacter] 2021 Jun; Vol. 26 (3), pp. e12801. Date of Electronic Publication: 2021 Mar 19.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9605411 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Bismuth-based quadruple therapy following H. pylori eradication failures: a multicenter study in clinical practice.

• Authors : Zullo A; Gastroenterology, Nuovo Regina Margherita Hospital, Rome, Italy. .; De Francesco V

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*administration & dosage ; Bismuth/Bismuth/Bismuth/*administration & dosage ; Esomeprazole/Esomeprazole/Esomeprazole/*administration & dosage

• Source: Journal of gastrointestinal and liver diseases : JGLD [J Gastrointestin Liver Dis] 2017 Sep; Vol. 26 (3), pp. 225-229.Publisher:

تفاصيل العنوان

The appropriate cutoff gastric pH value for Helicobacter pylori eradication with bismuth-based quadruple therapy.

• Authors : Ke H; Department of Gastroenterology, State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Li J

Subjects: Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/therapeutic use ; Bismuth*/Bismuth*/Bismuth*/therapeutic use ; Helicobacter Infections*/Helicobacter Infections*/Helicobacter Infections*/drug therapy

• Source: Helicobacter [Helicobacter] 2021 Feb; Vol. 26 (1), pp. e12768. Date of Electronic Publication: 2020 Oct 21.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9605411 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments.

• Authors : Gisbert JP; Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.; Romano M

Subjects: Amoxicillin/Amoxicillin/Amoxicillin/*therapeutic use ; Antacids/Antacids/Antacids/*therapeutic use ; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use

• Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2015 Apr; Vol. 41 (8), pp. 768-75. Date of Electronic Publication: 2015 Feb 23.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان